All News

    How Fall and My Daughter’s Cancer Go Together for Me

    September 4th 2025, 4:00pm

    Article

    As we head into Fall, I’ve been thinking about how much this season represents my daughter’s cancer experience for me.

    PredicineCARE Urine Test Advances in FDA Review for Bladder Cancer

    September 4th 2025, 3:05pm

    Article

    PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous data and biomarker insights.

    Facing Leukemia Again, Suleika Jaouad Lives Every Day like It’s Her First

    September 4th 2025, 1:00pm

    Video

    CURE spoke with the author of “Between Two Kingdoms” and “The Book of Alchemy” about the latest chapter in her cancer journey.

    FDA Grants Two Designations to TT125-802 for Mutated Lung Cancers

    September 3rd 2025, 9:00pm

    Article

    The FDA granted two fast track designations to TT125-802, an investigational therapy, for the treatment of advanced/metastatic non-small cell lung cancer.

    Targeted and Combination Therapies Reshape Leukemia Care

    September 3rd 2025, 8:00pm

    Video

    Advances in leukemia treatment now include targeted drugs, lighter chemotherapy and combination regimens that improve tolerance and reduce resistance.

    Prostate Cancer Awareness Month: Focus on Detection and Treatment

    September 3rd 2025, 7:00pm

    Article

    Dr. David A. Taub discussed why Prostate Cancer Awareness Month marks a time to highlight early detection and evolving treatment in an interview with CURE.

    Pushing My Reset Button: Finding Balance and Healing Through Cancer

    September 3rd 2025, 5:00pm

    Article

    Through exercise, meditation, and gratitude, I reset my mind and body, finding peace and strength in life after my cancer diagnosis.

    How Leukemia Treatment Has Evolved in Recent Years

    September 3rd 2025, 4:00pm

    Article

    In observation of Leukemia Awareness Month in September, CURE spoke with an expert about basics of the disease.

    Haystack MRD Test Gets Breakthrough Designation in Stage 2 Colorectal Cancer

    September 3rd 2025, 3:00pm

    Article

    The FDA granted breakthrough device designation to the Haystack MRD test, which uses ctDNA to detect residual or recurrent stage 2 colorectal cancer.

    How Patients With Kidney Cancer Can Advocate for Themselves in Care

    September 3rd 2025, 1:00pm

    Video

    Patients can best advocate for themselves by asking questions and remembering they have the right to be active participants in their care.